Stephen H Zinner

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Multidrug Resistant

Respiratory Tract

Highly Efficient

Genetic Diversity

Top Venues

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Elena N Strukova, Maria V Golikova, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner
Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing Klebsiella pneumoniae and the Inoculum Effect. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Elena N Strukova, Maria V Golikova, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner
Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing Klebsiella pneumoniae and the Inoculum Effect. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Kamilla N Alieva, Maria V Golikova, Anastasiya A Kuznetsova, Stephen H Zinner
Fluorescence Microscopy: Determination of Meropenem Activity against Klebsiella pneumoniae . Antibiotics (Basel, Switzerland) 12 (7) (2023)
Maria V Golikova, Kamilla N Alieva, Elena N Strukova, Daria A Kondratieva, Nika F Petrova, Mayya A Petrova, Stephen H Zinner
Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Maria V Golikova, Kamilla N Alieva, Elena N Strukova, Daria A Kondratieva, Nika F Petrova, Mayya A Petrova, Stephen H Zinner
Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Maria V Golikova, Elena N Strukova, Kamilla N Alieva, Vladimir A Ageevets, Alisa A Avdeeva, Ofeliia S Sulian, Stephen H Zinner
Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing Klebsiella pneumoniae . Antibiotics (Basel, Switzerland) 12 (5) (2023)
Maria V Golikova, Kamilla N Alieva, Alla V Filimonova, Vladimir A Ageevets, Ofeliia S Sulian, Alisa A Avdeeva, Sergey V Sidorenko, Stephen H Zinner
Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio. Biomedicines 10 (6) (2022)
Alla V Filimonova, Maria V Golikova, Elena N Strukova, Yury A Portnoy, Anastasiya A Kuznetsova, Stephen H Zinner
Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing Klebsiella pneumoniae in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination. Antibiotics (Basel, Switzerland) 10 (12) (2021)